Table 1.
2016-ACR-EULAR [14] | 2012-ACR [15] | 2002-AECG [16] | |
---|---|---|---|
ESSDAI ≥ 1 | + (Entry Criterion) | − | − |
Sicca Symptoms | + (Entry Criterion) | − | + |
Salivary Gland Biopsy | + | + | + |
Serology | |||
Anti-Ro/SSA | + | + | + |
Anti-La/SSB | − | + | + |
Antinuclear Antibodies | − | + | − |
Rheumatoid Factor | − | + | − |
Oral Signs | |||
UWS ≤ 0.1mL/Min | + | − | + |
Sialography | − | − | + |
Scintigraphy | − | − | + |
Ocular Signs | |||
Schirmer’s Test ≤ 5 | + | − | + |
Ocular Staining (OSS or vBv) | + | + | + |
ACR-EULAR: American College of Rheumatology-European League Against Rheumatism; ACR: American College of Rheumatology; AECG: American European Consensus Group; ESSDAI: EULAR Sjögren’s Syndrome Disease Activity Index; UWS: unstimulated whole saliva; OSS: ocular staining score; vBv: van Bijsterveld score.